OTC Markets OTCPK - Delayed Quote USD
ProtoKinetix, Incorporated (PKTX)
0.0100
0.0000
(0.00%)
At close: May 8 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
364.1880
364.1880
415.4790
1,907.3090
2,329.3100
Operating Income
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
Net Non Operating Interest Income Expense
0
--
--
--
--
Pretax Income
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
Net Income Common Stockholders
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
Diluted NI Available to Com Stockholders
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
Basic EPS
0.00
--
-0.01
-0.01
-0.01
Diluted EPS
0.00
--
-0.01
-0.01
-0.01
Basic Average Shares
358,557.9300
--
333,102.7540
307,392.0690
291,865.9220
Diluted Average Shares
358,557.9300
--
333,102.7540
307,392.0690
291,865.9220
Total Expenses
364.1880
364.1880
415.4790
1,907.3090
2,329.3100
Net Income from Continuing & Discontinued Operation
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
Normalized Income
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
Interest Expense
0
--
--
--
--
Net Interest Income
0
--
--
--
--
EBIT
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
EBITDA
-311.3180
-311.3180
-367.2200
-1,848.8590
-2,326.3100
Reconciled Depreciation
52.8700
52.8700
48.2580
58.4500
3
Net Income from Continuing Operation Net Minority Interest
-364.1880
-364.1880
-415.4790
-1,907.3090
-2,329.3100
Normalized EBITDA
-311.3180
-311.3180
-367.2200
-1,848.8590
-2,326.3100
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/22/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYMX Mymetics Corporation
0.0003
0.00%
RVX.TO Resverlogix Corp.
0.0450
0.00%
TRVN Trevena, Inc.
1.1500
+11.65%
ACIU AC Immune SA
1.6600
0.00%
AMLX Amylyx Pharmaceuticals, Inc.
4.5800
-5.95%
RLAY Relay Therapeutics, Inc.
3.0000
+1.69%
FGEN FibroGen, Inc.
0.3194
-2.02%
VIR Vir Biotechnology, Inc.
5.41
-3.57%
FATE Fate Therapeutics, Inc.
1.0300
+3.00%
ARVN Arvinas, Inc.
6.81
+2.10%